Biomerica, Inc. ( BMRA) - Key Metrics
BMRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0.38 | -$0.37 | -$0.24 | -$0.24 |
| 2026Q4 | $0.28 | -$0.37 | -$0.30 | -$0.31 |
| 2026Q3 | $0.33 | -$0.44 | -$0.42 | -$0.43 |
| 2026Q2 | $0.42 | -$0.45 | -$0.34 | -$0.33 |
| 2026Q1 | $0.52 | $0 | -$0.10 | -$0.10 |
BMRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -1.41 |
| 2026Q4 | 0% | -1.59 |
| 2026Q3 | 0% | -1.18 |
| 2026Q2 | 0% | -1.26 |
| 2026Q1 | 0% | 260.83 |
BMRA
Price: $1.72
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 8300
Ebitda: -223324Market Capitalization: 7.9 million